[Federal Register Volume 79, Number 139 (Monday, July 21, 2014)]
[Notices]
[Pages 42330-42331]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2014-17057]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Committee on Immunization Practices (ACIP)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announce the following meeting of the aforementioned
committee.
Time and Date: 2:00 p.m.-4:30 p.m. EDT, August 13, 2014.
Place: Teleconference.
Status: This meeting is open to the public, limited only by the
availability of telephone ports and webinar.
Participants can join the event directly at: https://www.mymeetings.com/nc/join.php?i=PW7936898&p=5994905&t=c. USA
Telephone Dial-in number: 1-800-369-1780. Participant passcode:
5994905 or URL: https://www.mymeetings.com/nc/join/.
Conference number: PW7936898.
Audience passcode: 5994905.
Purpose: The committee is charged with advising the Director,
CDC, on the appropriate use of immunizing agents. In addition, under
42 U.S.C. 1396s, the committee is mandated to establish and
periodically review and, as appropriate, revise the list of vaccines
for administration to vaccine-eligible children through the Vaccines
for Children (VFC) program, along with schedules regarding the
appropriate periodicity, dosage, and contra-indications applicable
to the vaccines. Further, under provisions of the Affordable Care
Act, at section 2713 of the Public Health Service Act, immunization
recommendations of the ACIP that have been adopted by the Director
of the Centers for Disease Control and Prevention must be covered by
applicable health plans.
Matters for Discussion: The agenda will include discussions on:
Use of 13-valent pneumococcal conjugate vaccine and 23-valent
pneumococcal polysaccharide vaccine in adults 65 years of age and
older. A recommendation vote is scheduled. Time will be available
for public comment.
Agenda items are subject to change as priorities dictate.
Contact Person for More Information: Stephanie B. Thomas,
National Center for Immunization and Respiratory Diseases, CDC, 1600
Clifton Road, NE., MS-A27, Atlanta, Georgia 30333, telephone 404/
639-8836; Email [email protected].
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining
to announcements of meetings and other committee management
activities for both the Centers for Disease Control and
[[Page 42331]]
Prevention and the Agency for Toxic Substances and Disease Registry.
Elaine Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2014-17057 Filed 7-18-14; 8:45 am]
BILLING CODE 4160-18-P